Edison note Further note issued recently re exosomes 200718 [link] and website updated re said recent presentation within note above [link] now detailing broad anti-cancer indication efficacy albeit only at moment in vitro at least some recent realisation from our company regarding commercialisation of our lines long time in coming but recent rns much welcome nevertheless perhaps we will have an rns re commercialising our exosome line in general - ie must be opportunities in generating revenues otherwise presentation slides indicate generally well into next calendar 2019 year for updates the bia have been noticeably absent btw in mentioning us for months now bw all mol
News out - intraday Not sure if I’ve posted this before but thought would do so now under this thread [link] [link] [link] just a bit of info and follow up re paulmc1 post re our rns release Feb 18 [link] mol
Latest Presentation Slides available [link] mol
OH excerpt on rns Whilst the rules re close periods are different under the new aim regulations and the Market Abuse Regulations I believe they can esp after release of rns. bit of info here [link] However I don’t expect them to mol
OH excerpt on rns Are they able to buy if they are part of commercial discussions? Just a question.
oxp
Estimated Enrollment: 12 Study Start Date: June 2010 Estimated Study Completion Date: March 2015 Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure) may be some news out soon.
Just upped my holding at 3.175p
I have been a holder of Rene shares for a few months so I thought it was about time to register on this forum. Thanks to you all as your comments have been so very helpful. I picked up a few more shares this morning ahead of the big potential price hike!